New center strengthens innovation in medical technology
The Center for Biomedical Mass Spectrometry and Optical Spectroscopy (CeMOS) is a new competence center at the Hochschule Mannheim University of Applied Sciences. Since its opening at the start of the year, CeMOS has been dedicated to cooperation between research and industry, including many SMEs. The program illustrates how medical innovation takes place in Germany.
CeMOS bundles the activities of the university's Medical Biotechnology/Medical Technology and Intelligent Sensors research groups. It is co-directed by professors Carsten Hopf and Matthias Rädle. At the time of the opening, Hopf said of the new center, "The aim is to generate synergies in the area of biomedical mass spectrometry and the development of optical devices in order to create new impulses for application-oriented projects with industrial partners."
The two research groups are already top-performers. Before they joined forces, they were bringing in more than EUR 2.5 million in funding from third parties – mainly industrial sponsors. Rädle expects this funding to grow now. "We expect CeMOS to have a positive effect on employment in the region's research and production industries. The Center will bring in third-party funding of EUR three million for the university and an additional EUR five million from external partners."
CeMOS already has a unique network that includes the University's medical program, around 100 industrial partners, and regional and city economic development associations. It also has access to infrastructure and equipment provided by the German Ministry of Education and Research and the German Research Association. "We want to exploit this network to cooperate with companies to create new applications for a range of product development strategies," said Hopf.